MDWD - Mediwound Ltd logo

Mediwound Ltd

MDWD

MediWound Ltd. develops and commercializes biotherapeutic solutions for tissue repair, including NexoBrid for burn treatment and EscharEx for chronic wounds. It serves burn centers and hospitals in the U.S., Europe, and internationally.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$262today

Score Overview

1 Year
Score
Net Growth-9.32%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-14.62%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.1
Net Growth-92.64%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-39.07%
Rev Trend40%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-38.23%
Net Trend40%
Net Income Consistency
Rev Growth9x
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-38.30%
Net Trend42%
Net Income Consistency
Rev Growth55x
Rev Trend67%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Mediwound Ltd has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. MDWD does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 12.18โ€”
1 Year2025-10-22
$ 18.60-34.52%
5 Years2021-10-22
$ 25.62-52.46%
10 Years2016-10-21
$ 46.55-73.83%
All Time2014-03-20
$ 120.89-89.92%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 14M-$ 26M$ 44M
2025$ 16M-$ 23M$ 53M
2024$ 20M-$ 30M$ 43M
2023$ 18M-$ 6M$ 41M
2022$ 26M-$ 19M$ 33M
2021$ 23M-$ 13M$ 11M
2020$ 21M-$ 9M$ 21M
2019$ 31M$ 4M$ 29M
2018$ 3M-$ 1M$ 23M
2017$ 2M-$ 22M$ 36M
2016$ 1M-$ 18M$ 30M
2015$ 601K-$ 22M$ 45M
IPO2014$ 259K-$ 18M$ 64M
MDWD - Mediwound Ltd logo

Mediwound Ltd fundamental performance

Between 2020 and 2025, revenue declined from $ 21M to $ 16M and net income went from -$ 9M to -$ 23M. Revenue increased in 2 of those 5 years; net income in 2.

Across Mediwound Ltd's full reported history, from 2014 to 2025, revenue grew from $ 259K to $ 16M and net income went from -$ 18M to -$ 23M. Revenue increased in 67% of the years measured; net income in 42%.

Mediwound Ltd currently holds a 5-year HDB Score of 3.1 out of 10. How the HDB Score is calculated.

Membership

Explore MDWD with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies